Sandbox Reserved 1794

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
[[image:Taurocholate.png|thumb|250 px| '''Fig. 1: Taurocholic acid a crystalline bile acid''']]
[[image:Taurocholate.png|thumb|250 px| '''Fig. 1: Taurocholic acid a crystalline bile acid''']]
-
Sodium Taurocholate Co-Transporting Polypeptide, or NTCP, is a [https://en.wikipedia.org/wiki/Membrane_transport_protein membrane transporter protein] found in the plasma membrane of [https://en.wikipedia.org/wiki/Hepatocyte hepatocytes]. NTCP's primary function is the transportation of [https://en.wikipedia.org/wiki/Taurocholic_acid taurocholates], or '''bile salts''', (Fig. 1) into the liver and out of the liver to the small intestine. <Ref> Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. PMID: 21103971. [https://dx.doi.org/10.1007/978-3-642-14541-4_5 DOI: DOI: 10.1007/978-3-642-14541-4_5]. </Ref> Bile salts play various roles in metabolism and digestion, but their main function is the [https://en.wikipedia.org/wiki/Emulsion emulsification] of lipid droplets into smaller fragments. This enables lipases to break down the droplets into their monomers, or triglycerides which are then able to be digested. NTCP is part of the [https://en.wikipedia.org/wiki/Solute_carrier_family solute carrier superfamily], SLC10. NTCP is the founding member of the SLC10 family, first discovered in rat hepatocytes in 1978. <ref name = "SLC10"> Geyer, J., Wilke, T. & Petzinger, E. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmied Arch Pharmacol 372, 413–431 (2006). https://doi.org/10.1007/s00210-006-0043-8 </ref> NTCP has a key role in [https://en.wikipedia.org/wiki/Enterohepatic_circulation enterohepatic circulation] or '''bile salt recycling''', and its unique ability to transport other solutes gives it therapeutic potential for lowering cholesterol and treating [https://en.wikipedia.org/wiki/Liver_disease liver disease]. <Ref name = "Goutam"/>
+
Sodium Taurocholate Co-Transporting Polypeptide, or NTCP, is a [https://en.wikipedia.org/wiki/Membrane_transport_protein membrane transporter protein] found in the plasma membrane of [https://en.wikipedia.org/wiki/Hepatocyte hepatocytes]. NTCP's primary function is the transportation of [https://en.wikipedia.org/wiki/Taurocholic_acid taurocholates], or '''bile salts''', (Fig. 1) into the liver and out of the liver to the small intestine. <Ref> Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. PMID: 21103971. [https://dx.doi.org/10.1007/978-3-642-14541-4_5 DOI: DOI: 10.1007/978-3-642-14541-4_5]. </Ref> Bile salts play various physiological roles in metabolism and digestion, but their main function is the [https://en.wikipedia.org/wiki/Emulsion emulsification] of lipid droplets into smaller fragments. This enables lipases to break down the droplets into their monomers, or triglycerides which are then able to be digested. NTCP is part of the [https://en.wikipedia.org/wiki/Solute_carrier_family solute carrier superfamily], SLC10. NTCP is the founding member of the SLC10 family, first discovered in rat hepatocytes in 1978. <ref name = "SLC10"> Geyer, J., Wilke, T. & Petzinger, E. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmied Arch Pharmacol 372, 413–431 (2006). https://doi.org/10.1007/s00210-006-0043-8 </ref> NTCP has a key role in [https://en.wikipedia.org/wiki/Enterohepatic_circulation enterohepatic circulation] or '''bile salt recycling''', and its unique ability to transport other solutes gives it therapeutic potential for lowering cholesterol and treating [https://en.wikipedia.org/wiki/Liver_disease liver disease]. <Ref name = "Goutam"/>
In addition to its physiological role in bile salt transport, NTCP also serves as a binding site for [https://en.wikipedia.org/wiki/Hepatitis_B hepatitis B virus] and [https://en.wikipedia.org/wiki/Hepatitis_D hepatitis D virus]. <ref name = "Park"> Park, JH., Iwamoto, M., Yun, JH. et al. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature 606, 1027–1031 (2022). https://doi.org/10.1038/s41586-022-04857-0. </ref> Understanding the HBV and HDV binding mechanism to NTCP may aid in the development of new viral inhibitors.
In addition to its physiological role in bile salt transport, NTCP also serves as a binding site for [https://en.wikipedia.org/wiki/Hepatitis_B hepatitis B virus] and [https://en.wikipedia.org/wiki/Hepatitis_D hepatitis D virus]. <ref name = "Park"> Park, JH., Iwamoto, M., Yun, JH. et al. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature 606, 1027–1031 (2022). https://doi.org/10.1038/s41586-022-04857-0. </ref> Understanding the HBV and HDV binding mechanism to NTCP may aid in the development of new viral inhibitors.
Line 14: Line 14:
=== Overview ===
=== Overview ===
-
NTCP is one continuous polypeptide chain containing <scene name='95/952722/Labeled_9_helices/5'>9 transmembrane alpha helices</scene>.<ref name="Goutam"/> The N-terminus of the polypeptide chain extrudes into the extracellular region of the plasma membrane while the C-terminus juts into the intracellular region. NTCP contains <scene name='95/952722/Ntcp_core_domain-_blue/10'>Two distinct sub domains</scene>: a core domain and a panel domain, which together channel opening and bile salt transport (Fig. 2). The <scene name='95/952722/Ntcp_core_domain-_blue/8'>core domain</scene> <font color='#6060ff'><b>(blue)</b></font> contains 6 transmembrane &alpha; helices (TM2-4 and TM7-9) and demonstrates [https://en.wikipedia.org/wiki/Protein_structure two-fold pseudosymmetry]. The <scene name='95/952722/Ntcp_panel_domain-_red/4'>panel domain</scene> <font color='red'><b>(red)</b></font> consists of 3 transmembrane &alpha; helices (TM1 and TM5-6) and is asymmetrical. Within the core domain, a unique crossover between TM-3 and TM-8 creates an <scene name='95/952722/Ntcp_x_motif/14'>X motif</scene>. The X motif contains the substrate binding site and essential residues for the conformational change required for transport. The core and panel domains are also connected by both extracellular and intracellular <scene name='95/952722/Connector_helices/6'>connector helices</scene> that are separate from the <scene name='95/952722/Labeled_9_helices/5'>9 transmembrane alpha helices</scene>.
+
The overall structure of NTCP is one continuous polypeptide chain containing <scene name='95/952722/Labeled_9_helices/5'>9 transmembrane alpha helices</scene> embedded in the plasma membrane.<ref name="Goutam"/> The N-terminus of this polypeptide chain extrudes into the extracellular region of the plasma membrane while the C-terminus juts into the intracellular region. NTCP contains <scene name='95/952722/Ntcp_core_domain-_blue/10'>two distinct sub domains</scene>: a core domain and a panel domain, which together channel opening and bile salt transport (Fig. 2). The <scene name='95/952722/Ntcp_core_domain-_blue/8'>core domain</scene> <font color='#6060ff'><b>(blue)</b></font> contains 6 transmembrane &alpha; helices (TM2-4 and TM7-9) and demonstrates [https://en.wikipedia.org/wiki/Protein_structure two-fold pseudosymmetry]. The <scene name='95/952722/Ntcp_panel_domain-_red/4'>panel domain</scene> <font color='red'><b>(red)</b></font> consists of 3 transmembrane &alpha; helices (TM1 and TM5-6) and is asymmetrical. Within the core domain, a unique crossover between TM-3 and TM-8 creates an <scene name='95/952722/Ntcp_x_motif/14'>X motif</scene>. The X motif contains the substrate binding site and essential residues for the conformational change required for transport. The core and panel domains are also connected by both extracellular and intracellular <scene name='95/952722/Connector_helices/6'>connector helices</scene> that are separate from the <scene name='95/952722/Labeled_9_helices/5'>9 transmembrane alpha helices</scene>. All of these structural components of NTCP contribute to the transport of bile salts in and out of the liver.

Revision as of 14:30, 20 April 2023

Sodium Taurocholate Co-Transporting Polypeptide

Drag the structure with the mouse to rotate

References

  1. Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. PMID: 21103971. DOI: DOI: 10.1007/978-3-642-14541-4_5.
  2. Geyer, J., Wilke, T. & Petzinger, E. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmied Arch Pharmacol 372, 413–431 (2006). https://doi.org/10.1007/s00210-006-0043-8
  3. 3.0 3.1 3.2 3.3 3.4 3.5 Goutam, K., Ielasi, F.S., Pardon, E. et al. Structural basis of sodium-dependent bile salt uptake into the liver. Nature 606, 1015–1020 (2022). DOI: 10.1038/s41586-022-04723-z.
  4. 4.0 4.1 4.2 Park, JH., Iwamoto, M., Yun, JH. et al. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature 606, 1027–1031 (2022). https://doi.org/10.1038/s41586-022-04857-0.
  5. Qi X. and Li W. (2022). Unlocking the secrets to human NTCP structure. The Innovation 3(5), 100294. https://doi.org/10.1016/j.xinn.2022.100294
  6. 6.0 6.1 6.2 Liu, H., Irobalieva, R.N., Bang-Sørensen, R. et al. Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver. Cell Res 32, 773–776 (2022). https://doi.org/10.1038/s41422-022-00680-4
  7. Latorraca, N. R.; Fastman, N. M.; Venkatakrishnan, A. J.; Frommer, W. B.; Dror, R. O.; Feng, L. Mechanism of Substrate Translocation in an Alternating Access Transporter. Cell 2017, 169 (1), 96–107.
  8. 8.0 8.1 8.2 8.3 Asami, J., Kimura, K.T., Fujita-Fujiharu, Y. et al. Structure of the bile acid transporter and HBV receptor NTCP. Nature 606, 1021–1026 (2022). https://doi.org/10.1038/s41586-022-04845-4
  9. Grove, J.; Marsh, M. The Cell Biology of Receptor-Mediated Virus Entry. Journal of Cell Biology 2011, 195 (7), 1071–1082.
  10. 10.0 10.1 Herrscher C, Roingeard P, Blanchard E. Hepatitis B Virus Entry into Cells. Cells. 2020 Jun 18;9(6):1486. doi: 10.3390/cells9061486. PMID: 32570893; PMCID: PMC7349259.

Student Contributors

  • Isabelle White
  • Lena Barko
Personal tools